YZIQYBHFPOAMLY-OOXUFLSTSA-N
C34H35ClF2N8O4 — CID 139304623
Data last refreshed: (MolForge compound catalog, from PubChem)
About YZIQYBHFPOAMLY-OOXUFLSTSA-N
YZIQYBHFPOAMLY-OOXUFLSTSA-N (PubChem CID 139304623) has the molecular formula C34H35ClF2N8O4 and a molecular weight of 693.16 g/mol. Its IUPAC name is [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-(6-oxo-1H-pyrimidin-2-yl)phenyl]ethyl] N-cyclopropylcarbamate.
Molecular Properties
| Compound Name | YZIQYBHFPOAMLY-OOXUFLSTSA-N |
|---|---|
| PubChem CID | 139304623 |
| Molecular Formula | C34H35ClF2N8O4 |
| Molecular Weight | 693.16 g/mol |
| Exact Mass | 692.24 |
| IUPAC Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-(6-oxo-1H-pyrimidin-2-yl)phenyl]ethyl] N-cyclopropylcarbamate |
| SMILES | CC(C)(C)C[C@]1(c2ccc(-c3cnn(C(F)F)c3)cc2)N=C(N)N([C@H](COC(=O)NC2CC2)c2ccc(Cl)c(-c3nccc(=O)[nH]3)c2)C1=O |
| InChI | InChI=1S/C34H35ClF2N8O4/c1-33(2,3)18-34(22-7-4-19(5-8-22)21-15-40-44(16-21)30(36)37)29(47)45(31(38)43-34)26(17-49-32(48)41-23-9-10-23)20-6-11-25(35)24(14-20)28-39-13-12-27(46)42-28/h4-8,11-16,23,26,30H,9-10,17-18H2,1-3H3,(H2,38,43)(H,41,48)(H,39,42,46)/t26-,34-/m1/s1 |
| InChIKey | YZIQYBHFPOAMLY-OOXUFLSTSA-N |
| XLogP | 5.77 |
| TPSA | 160.59 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 693.16 |
| LogP ≤ 5 | 5.77 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139304623 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.